Evidence map›Paper›PMID 42834238›Full record

ReviewInnere Medizin (Heidelberg, Germany)2026

[The Nephrogeriatrics Research Network-achieving more through interdisciplinary approaches].

Maximilian König, Anna Maria Affeldt, Lena Schulte-Kemna, Susanne Fleig, Anastasia Paulmann, Hristos Karakizlis, Polina Todorova, Lukas Eberwein, Elke Schäffner, Clemens Grupp and 2 more

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maximilian KönigKlinik und Poliklinik für Innere Medizin D - Geriatrie, Universitätsmedizin Greifswald, Greifswald, Deutschland.
Anna Maria AffeldtKlinik II für Innere Medizin und Zentrum für Molekulare Medizin Köln, Medizinische Fakultät, Universität zu Köln, Köln, Deutschland.
Lena Schulte-KemnaKlinik für Innere Medizin I, Universitätsklinik Ulm, Ulm, Deutschland.
Susanne FleigMedizinische Klinik II, Klinik für Nieren- und Hochdruckkrankheiten, rheumatologische und immunologische Erkrankungen, RWTH Aachen, Aachen, Deutschland.
Anastasia PaulmannMount Desert Island Biological Laboratory (MDIBL), Bar Harbor, ME, USA.
Hristos KarakizlisMedizinische Klinik III (Klinik für Geriatrie, Allgemeine Innere Medizin und Nephrologie), Städtisches Klinikum Solingen, Solingen, Deutschland.
Polina TodorovaKlinik für Nephrologie, Uniklinik Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
Lukas EberweinMedizinische Klinik II, Nephrologie und Nierentransplantation, Universitätsklinik Gießen, Justus-Liebig-Universität Gießen, Gießen, Deutschland.
Elke SchäffnerInstitut für Public Health, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
Clemens GruppAbteilung Nephrologie und Rheumatologie, Georg-August-Universität Göttingen, Göttingen, Deutschland.
Sarah-Yasmin ThomsenKlinik für Nephrologie und Hypertonie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Kiel, Deutschland.
Ute HoffmannKlinik für Allgemeine Innere Medizin und Geriatrie, Krankenhaus Barmherzige Brüder Regensburg, Prüfeninger Straße 86, 93049, Regensburg, Deutschland. ute.hoffmann@barmherzige-regensburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interface between nephrology and geriatrics is becoming increasingly important. As the population ages, chronic kidney disease (CKD) in older adults is increasingly important. The physiological decline in renal function, combined with the high burden of comorbidities in older people, contributes substantially to the high prevalence of CKD in later life and to the increasing number of affected individuals. Reduced kidney function is closely associated with multimorbidity, polypharmacy, functional decline, cognitive impairment, and frailty.The specialties geriatrics and nephrology both focus on holistic, complex-care, in which multimorbidity management, individualized treatment planning, and the preservation of functional independence are central goals. Despite this conceptual overlap, an integrated nephrogeriatric perspective has not been adequately incorporated into research and clinical care.Against this background, the Nephrogeriatrics Research Network was established in 2024. As an open, interdisciplinary network, it promotes collaboration among researchers working at the intersection of nephrology and geriatrics, brings together clinical and methodological expertise, and-in close affiliation with DGG (Deutsche Gesellschaft für Geriatrie) and DGfN (Deutsche Gesellschaft für Nephrologie)-enhances the visibility of the field. The goals are to strengthen the evidence base for older, multimorbid individuals with CKD through multicenter, translational, research approaches and provide a central platform.

Indexed as

Chronic kidney disease (CKD)Healthcare strategiesMultimorbidityNephrogeriaticsResearch network

Identifiers

PMID42834238

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.